-
Amicizia D, Domnich A, Panatto D, Lai P L, Cristina M L, Avio U, Gasparini R, 2013: Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines[J]. Hum Vaccin Immunother, 9, 1163-1171. doi: 10.4161/hv.23802
-
Blutt S E, Miller A D, Salmon S L, Metzger D W, Conner M E, 2012: IgA is important for clearance and critical for protection from rotavirus infection[J]. Mucosal Immunol, 5, 712-719. doi: 10.1038/mi.2012.51
-
Coffman R L, Sher A, Seder R A, 2010: Vaccine adjuvants:putting innate immunity to work[J]. Immunity, 4, 492-503.
-
Demento S L, Siefert A L, Bandyopadhyay A, Sharp F A, Fahmy T M, 2011: Pathogen-associated molecular patterns on biomaterials:a paradigm for engineering new vaccines[J]. Trends Biotechnol., 29, 294-306. doi: 10.1016/j.tibtech.2011.02.004
-
Dorozhkin S V, Epple M, 2002: Biological and medical sig-nificance of calcium phosphates[J]. Angew. Chem. Int. Ed., 41, 3130-3146. doi: 10.1002/1521-3773(20020902)41:17
-
Epand R M, Vogel H J, 1999: Diversity of antimicrobial pep-tides and their mechanisms of action[J]. Biochim. Biophys. Acta, 1462, 11-28. doi: 10.1016/S0005-2736(99)00198-4
-
Franchi L, Kamada N, Nakamura Y, Burberry A, Kuffa P, Suzuki S, Shaw M H, Kim Y G, Núñz G, 2012: NLRC4-driven inter-leukin-1β production discriminates between pathogenic and com-mensal bacteria and promotes host intestinal defense[J]. Nat. Immunol., 13, 449-456. doi: 10.1038/ni.2263
-
Frisdal E, Lesnik P, Olivier M, Robillard P, Chapman M J, Huby T, Guerin M, Le Goff W, 2011: Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenu-ates the proinflammatory response[J]. J. Biol. Chem., 35, 30926-30936.
-
Harandi A M, Medaglini D, Shattock R J, 2010: Vaccine adju-vants:a priority for vaccine research[J]. Vaccine, 28, 2363-2366. doi: 10.1016/j.vaccine.2009.12.084
-
Honko A N, Mizel S B, 2005: Effects of flagellin on innate and adaptive immunity[J]. Immunol Res, 33, 83-101. doi: 10.1385/IR:33:1:083
-
Klinman D M, Klaschik S, Sato T, Tross D, 2009: CpG oligo-nucleotides as adjuvants for vaccines targeting infectious diseases[J]. Adv. Drug Deliv. Rev., 61, 248-255. doi: 10.1016/j.addr.2008.12.012
-
Knuschke T, Sokolova V, Rotan O, Wadwa M, Tenbusch M, Han-sen W, Staeheli P, Epple M, Buer J, Westendorf A M, 2013: Immunization with biodegradable nanoparticles efficiently in-duces cellular immunity and protects against influenza virus in-fection[J]. J. Immunol., 190, 6221-6229. doi: 10.4049/jimmunol.1202654
-
Kozlova D, Chernousova S, Knuschke T, Buer J, Westendorf A M, Epple M, 2012: Cell targeting by antibody-functionalized calcium phosphate nanoparticles[J]. J. Mater. Chem., 22, 396-404. doi: 10.1039/C1JM14683A
-
Krishnamachari Y, Salem A K, 2009: Innovative strategies for co-delivering antigens and CpG oligonucleotides[J]. Adv. Drug Deliv. Rev., 61, 205-217. doi: 10.1016/j.addr.2008.12.013
-
Liu F, Yang J, Zhang Y, Zhou D, Chen Y, Gai W, Shi W, Li Q, Tien P, Yan H, 2010: Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy[J]. Biochem. Biophys. Res. Commun., 392, 582-587. doi: 10.1016/j.bbrc.2010.01.077
-
Mbow M L, De Gregorio E, Valiante N M, Rappuoli R, 2010: New adjuvants for human vaccines[J]. Curr. Opin. Immunol., 22, 411-416. doi: 10.1016/j.coi.2010.04.004
-
Miao E A, Andersen-Nissen E, Warren S E, Aderem A, 2007: TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system[J]. Semin. Immunopathol., 29, 275-288. doi: 10.1007/s00281-007-0078-z
-
Mizel S B, Bates J T, 2010: Flagellin as an adjuvant: cellular mechanisms and potential[J]. J. Immunol., 185, 5677-5682. doi: 10.4049/jimmunol.1002156
-
Neumann S, Kovtun A, Dietzel I D, Epple M, Heumann R, 2009: The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium dis-turbance during transfection[J]. Biomaterials, 30, 6794-6802. doi: 10.1016/j.biomaterials.2009.08.043
-
Shi W, Li Y H, Liu F, Yang J Y, Zhou D H, Chen Y Q, Zhang Y, Yang Y, He B X, Han C, Fan M W, Yan H M, 2012: Flagel-lin enhances saliva IgA response and protection of anti-caries DNA vaccine[J]. J. Dent. Res., 91, 249-254. doi: 10.1177/0022034511424283
-
Sokolova V, Knuschke T, Buer J, Westendorf A M, Epple M, 2011: Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells[J]. Acta Biomater., 7, 4029-4036. doi: 10.1016/j.actbio.2011.07.010
-
Sokolova V, Knuschke T, Kovtun A, Buer J, Epple M, Westendorf A M, 2010: The use of calcium phosphate nanoparti-cles encapsulating toll-like receptor ligands and the antigen he-magglutinin to induce dendritic cell maturation and T cell acti-vation[J]. Biomaterials, 31, 5627-5633. doi: 10.1016/j.biomaterials.2010.03.067
-
Sokolova V, Kozlova D, Knuschke T, Buer J, Westendorf A M, Epple M, 2013: Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells[J]. Acta Biomater., 9, 7527-7535. doi: 10.1016/j.actbio.2013.02.034
-
Sokolova V, Rotan O, Klesing J, Nalbant P, Buer J, Knuschke T, Westendorf A M, Epple M, 2012: Calcium phosphate nano-particles as versatile carrier for small and large molecules across cell membranes[J]. J. Nanopart. Res., 14, 910-. doi: 10.1007/s11051-012-0910-9
-
Sun Y, Shi W, Yang J Y, Zhou D H, Chen Y Q, Zhang Y, Yang Y, He B X, Zhong M H, Li Y M, Cao Y, Xiao Y, Li W, Yu J, Li Y H, Fan M W, Yan H M, 2012: Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine[J]. J. Dent. Res., 91, 941-947. doi: 10.1177/0022034512457684
-
Vijay-Kumar M, Carvalho F A, Aitken J D, Fifadara N H, Gewirtz A T, 2010: TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin[J]. Eur. J. Immunol., 12, 3528-3534.
-
Wischke C, Zimmermann J, Wessinger B, Schendler A, Borchert H H, Peters J H, Nesselhut T, Lorenzen D R, 2009: Poly(I:C) coated PLGA microparticles induce dendritic cell maturation[J]. Int. J. Pharm., 1-2, 61-68.
-
Yan H, Lamm M E, Bjöling E, Huang Y T, 2002: Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model[J]. J. Virol., 76, 10972-10979. doi: 10.1128/JVI.76.21.10972-10979.2002
-
Yang J, Zhong M, Zhang Y, Zhang E, Sun Y, Cao Y, Li Y, Zhou D, He B, Chen Y, Yang Y, Yu J, Yan H, 2013: Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization[J]. Hum. Vaccin. Immunother., 9, 1084-1092. doi: 10.4161/hv.23809
-
Yang J, Zhang E, Liu F, Zhang Y, Zhong M, Li Y, Zhou D, Chen Y, Cao Y, Xiao Y, He B, Yang Y, Sun Y, Lu M, and Yan H. 2013. Flagellins of Salmonella Typhi and non-pathogenic Escherichia coli are differentially recognized through NLRC4 pathway in macrophages. J. Innate Immunity: (in press).